ANTEROGEN.CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,360 KRW | +0.85% |
|
+6.30% | -10.12% |
ANTEROGEN CO.,LTD. is a Korea-based company mainly engaged in the manufacture of cell therapy products. The Company's product portfolio consists of Cupistem which is used for the treatment of Crohnâs fistula by using autologous adipose-derived mesenchymal stem cells; stem cell conditioned medias (SCMs), SCM2s, and Therastem-dermas which are used for strengthening the function of skin as cosmetic raw materials; Remodullins which are used for the treatment of pulmonary arterial hypertension (PAH) and other products which are used for testing services. The Company distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -10.12% | 108M | |
| -2.47% | 89.37B | |
| +2.76% | 40.65B | |
| -13.73% | 32.81B | |
| +52.41% | 25B | |
| -17.31% | 15.29B | |
| -42.45% | 11.61B | |
| -10.48% | 11.49B | |
| +6.14% | 8.98B | |
| -7.72% | 8.23B |
- Stock Market
- Equities
- A065660 Stock
- Funds and ETFs Anterogen.Co.,Ltd.
